Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
Baird Starts Mind Medicine (MindMed) With Outperform Rating, $27 Price Target
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
HC Wainwright & Co. Maintains Buy on Mind Medicine, Lowers Price Target to $35
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
RBC Lifts Price Target on Mind Medicine (MindMed) to $15 From $14, Notes Imminent Durability Data; Outperform, Speculative Risk Kept
Mind Medicine (MMED) Receives a Buy From Maxim Group
Maxim Group Maintains Their Buy Rating on Mind Medicine (MMED)
Mind Medicine Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Mind Medicine, Maintains $7 Price Target
Mind Medicine Analyst Ratings
Mind Medicine (MMED) Gets a Buy Rating From H.C. Wainwright